These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25036234)

  • 1. Erythematosus plaques with macrophage infiltration as an initial manifestation of macrophage activation syndrome in a patient with systemic lupus erythematosus.
    Tochihara M; Kasai M; Katsumata Y; Sato E; Ishiguro N; Kazama H; Sugimoto N; Ichida H; Kawaguchi Y; Yamanaka H
    Mod Rheumatol; 2016 Nov; 26(6):956-957. PubMed ID: 25036234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome.
    Shimizu M; Yokoyama T; Tokuhisa Y; Ishikawa S; Sakakibara Y; Ueno K; Yachie A
    Clin Immunol; 2013 Feb; 146(2):73-6. PubMed ID: 23291246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
    Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
    Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?
    Pringe A; Trail L; Ruperto N; Buoncompagni A; Loy A; Breda L; Martini A; Ravelli A
    Lupus; 2007; 16(8):587-92. PubMed ID: 17711893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
    Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
    Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
    Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
    Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
    Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
    Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and correct diagnosis of macrophage activation syndrome.
    Cron RQ; Davi S; Minoia F; Ravelli A
    Expert Rev Clin Immunol; 2015; 11(9):1043-53. PubMed ID: 26082353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review.
    Vilaiyuk S; Sirachainan N; Wanitkun S; Pirojsakul K; Vaewpanich J
    Clin Rheumatol; 2013 Jun; 32(6):899-904. PubMed ID: 23483294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
    Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
    J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center.
    Dall'Ara F; Cavazzana I; Frassi M; Taraborelli M; Fredi M; Franceschini F; Andreoli L; Rossi M; Cattaneo C; Tincani A; Airò P
    Reumatismo; 2018 Jul; 70(2):100-105. PubMed ID: 29976044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation syndrome resistant to medical therapy in a patient with systemic lupus erythematosus and its remission with splenectomy.
    Kim JM; Kwok SK; Ju JH; Park KS; Park GS; Kim HY; Park SH
    Rheumatol Int; 2013 Mar; 33(3):767-71. PubMed ID: 21120496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide.
    Torres Jiménez A; Solís Vallejo E; Zeferino Cruz M; Céspedes Cruz A; Sánchez Jara B
    Reumatol Clin; 2014; 10(5):331-5. PubMed ID: 24035795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation syndrome as initial presentation of systemic lupus erythematosus.
    Yeap ST; Sheen JM; Kuo HC; Hwang KP; Yang KD; Yu HR
    Pediatr Neonatol; 2008 Apr; 49(2):39-42. PubMed ID: 18947015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome.
    Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
    Semin Arthritis Rheum; 2017 Oct; 47(2):216-221. PubMed ID: 28268026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage Activation Syndrome (MAS) in a Recently Released Prisoner with Systemic Lupus Erythematosus (SLE).
    Szulawski R; Kourlas PJ; Antonchak M
    Am J Case Rep; 2018 Jun; 19():734-738. PubMed ID: 29930239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients.
    Gavand PE; Serio I; Arnaud L; Costedoat-Chalumeau N; Carvelli J; Dossier A; Hinschberger O; Mouthon L; Le Guern V; Korganow AS; Poindron V; Gourguechon C; Lavigne C; Maurier F; Labro G; Heymonet M; Artifoni M; Viau AB; Deligny C; Sene T; Terriou L; Sibilia J; Mathian A; Bloch-Queyrat C; Larroche C; Amoura Z; Martin T
    Autoimmun Rev; 2017 Jul; 16(7):743-749. PubMed ID: 28483541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
    Aoyama-Maeda N; Horino T; Ichii O; Terada Y
    Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemophagocytic syndrome as the initial manifestation of systemic lupus erythematosus.
    Egües Dubuc CA; Uriarte Ecenarro M; Meneses Villalba C; Aldasoro Cáceres V; Hernando Rubio I; Belzunegui Otano J
    Reumatol Clin; 2014; 10(5):321-4. PubMed ID: 24316336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.